Product Images Nexesta Fe

This appears to be a list of studies related to contraceptive use among women. Some studies are mentioned by name and year, and their use of contraception is noted either as "ever use" or "current use." However, there is also some garbled text and numbers that are not readable.*

This text is providing information about different types of birth control methods and their effectiveness. The number of pregnancies per 100 women in one year is shown for each method, ranging from fewer than one to 85 or more. The different birth control methods are categorized as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*

Nexesta Fe is a combination of norethindrone and ethinyl estradiol tablets along with ferrous fumarate tablets. The tablet is chewable and available in multiple strengths of 0.4mg and 0.035mg. The tablets are divided into four weeks for an entire cycle with Week 4 being inactive. Figure A is also available with an unclear representation.*

This is a description of a pharmaceutical product called "NexestaTM Fe". Each package of NexestaTM Fe contains 21 white to off-white tablets which contain norethindrone USP 0.4 mg and ethinyl estradiol USP 0.035 mg, and 7 brown tablets which contain ferrous fumarate USP 75 mg. This product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. The package contains one blister pack of 28 tablets, and for adverse reactions contact Aurobindo Pharma USA, Inc.*

This appears to be the packaging information for Exesta Fe, which is a prescription medication that contains Norethindrone and Ethinyl Estradiol, as well as Ferrous Fumarate. These chewable tablets are used to prevent pregnancy and also help with iron deficiency. The dosage is 0.4mg/0.035mg.*